AU516471B2 – Administration of cromoglycic acid
– Google Patents
AU516471B2 – Administration of cromoglycic acid
– Google Patents
Administration of cromoglycic acid
Info
Publication number
AU516471B2
AU516471B2
AU58966/80A
AU5896680A
AU516471B2
AU 516471 B2
AU516471 B2
AU 516471B2
AU 58966/80 A
AU58966/80 A
AU 58966/80A
AU 5896680 A
AU5896680 A
AU 5896680A
AU 516471 B2
AU516471 B2
AU 516471B2
Authority
AU
Australia
Prior art keywords
administration
cromoglycic acid
cromoglycic
acid
Prior art date
1979-06-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU58966/80A
Other versions
AU5896680A
(en
Inventor
David Michael Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1979-06-05
Filing date
1980-06-02
Publication date
1981-06-04
1980-06-02
Application filed by Fisons Ltd
filed
Critical
Fisons Ltd
1980-12-11
Publication of AU5896680A
publication
Critical
patent/AU5896680A/en
1981-06-04
Application granted
granted
Critical
1981-06-04
Publication of AU516471B2
publication
Critical
patent/AU516471B2/en
2000-06-02
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
AU58966/80A
1979-06-05
1980-06-02
Administration of cromoglycic acid
Ceased
AU516471B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB7919516
1979-06-05
GB7919516
1979-06-05
Publications (2)
Publication Number
Publication Date
AU5896680A
AU5896680A
(en)
1980-12-11
AU516471B2
true
AU516471B2
(en)
1981-06-04
Family
ID=10505646
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU58966/80A
Ceased
AU516471B2
(en)
1979-06-05
1980-06-02
Administration of cromoglycic acid
Country Status (3)
Country
Link
US
(1)
US4268519A
(en)
AU
(1)
AU516471B2
(en)
DE
(1)
DE3021170A1
(en)
Families Citing this family (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB2167300B
(en)
*
1984-11-23
1988-11-23
Fisons Plc
Formulations
US8318817B2
(en)
2008-07-21
2012-11-27
Otonomy, Inc.
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US20160367520A1
(en)
2014-02-10
2016-12-22
Patara Pharma, LLC
Mast cell stabilizers for lung disease treatment
CA2938994A1
(en)
2014-02-10
2015-08-13
Patara Pharma, LLC
Inhalable formulations of sodium cromolyn with improved bioavailability
WO2017027402A1
(en)
2015-08-07
2017-02-16
Patara Pharma, LLC
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3331522A1
(en)
2015-08-07
2018-06-13
Patara Pharma LLC
Methods for the treatment of mast cell related disorders with mast cell stabilizers
AU2017321495A1
(en)
2016-08-31
2019-03-21
Respivant Sciences Gmbh
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
US11040004B2
(en)
2016-09-16
2021-06-22
Otonomy, Inc.
Otic gel formulations for treating otitis externa
JP2019531308A
(en)
2016-10-07
2019-10-31
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ
Cromolyn composition for the treatment of pulmonary fibrosis
US20220387408A1
(en)
2019-11-12
2022-12-08
INSERM (Institut National de la Santé et de la Recherche Médicale)
Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction
Family Cites Families (8)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3686412A
(en)
*
1965-03-25
1972-08-22
Colin Fitzmaurice
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
US3777033A
(en)
*
1965-03-25
1973-12-04
Fisons Pharmaceuticals Ltd
Bis-chromonyl pharmaceutical composi-tion and methods
US3720690A
(en)
*
1970-04-10
1973-03-13
Fisons Pharmaceuticals Ltd
Pharmaceutically active bis-carboxychromone compounds
US3975536A
(en)
*
1971-05-12
1976-08-17
Fisons Limited
Composition
US4152448A
(en)
*
1972-02-15
1979-05-01
Fisons Limited
Method and composition for the treatment of a condition of the gastro intestinal tract
US4029761A
(en)
*
1974-10-19
1977-06-14
Fisons Limited
Method for treating gingivitis
IE41922B1
(en)
*
1974-11-09
1980-04-23
Fisons Ltd
Pharmaceutical compositions containing bis-chromones
US4067992A
(en)
*
1975-09-10
1978-01-10
Fisons Limited
Method of treating a psychiatric condition
1980
1980-05-08
US
US06/147,917
patent/US4268519A/en
not_active
Expired – Lifetime
1980-06-02
AU
AU58966/80A
patent/AU516471B2/en
not_active
Ceased
1980-06-04
DE
DE19803021170
patent/DE3021170A1/en
not_active
Withdrawn
Also Published As
Publication number
Publication date
US4268519A
(en)
1981-05-19
AU5896680A
(en)
1980-12-11
DE3021170A1
(en)
1980-12-11
Similar Documents
Publication
Publication Date
Title
AU535198B2
(en)
1984-03-08
Preparation of clavulanic acid
AU516719B2
(en)
1981-06-18
Preparation of cis-hexahydrodibenzopyranones
NZ193078A
(en)
1981-11-19
Derivatives of 9-aminoalkyl-flyorene medicinal preparations
AU516471B2
(en)
1981-06-04
Administration of cromoglycic acid
AU5147679A
(en)
1980-05-22
Preparation of 2-chlorosulfinylazetidinones
AU515286B2
(en)
1981-03-26
Derivatives of 3-sulphamoyl 5-pyrrolyalkylbenzoic acid
AU6243480A
(en)
1981-03-26
Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid
AU564500B2
(en)
1987-08-13
Preparation of 7-acylindolin-2-ones
AU500707B1
(en)
1979-05-31
Preparation of 6-aminopenicillanic acid
AU533114B2
(en)
1983-11-03
Preparation of 3-o-demethylfortimicins
AU535357B2
(en)
1984-03-15
Stable pharmaceutical solution
AU527694B2
(en)
1983-03-17
Manufacture of fusecord
AU532673B2
(en)
1983-10-06
Preparation of omega-lactams
AU526438B2
(en)
1983-01-13
Administration set
AU515916B2
(en)
1981-05-07
Ethers of clavulanic acid
AU5894180A
(en)
1981-01-15
Preparation of pyrenzepine
JPS5615263A
(en)
1981-02-14
Manufacture of percarboxylic acid
AU5710280A
(en)
1980-10-09
Preparation of substituted 2-aminopyrazines
AU529069B2
(en)
1983-05-26
Preparation of tetramisole
JPS5566521A
(en)
1980-05-20
Manufacture of solid drug
AU516399B2
(en)
1981-06-04
Preparation of pyrrolo-benzoic acid derivatives
AU528421B2
(en)
1983-04-28
Inhalation administration of cromoglycate
AU492025B2
(en)
1977-07-28
Derivatives of aminoethylcyclohexane-carboxylic acid
AU6259180A
(en)
1981-04-09
Peptide derivatives of phosphoric acid
AU520396B2
(en)
1982-01-28
Preparation of thiazoline-4-one-acetic acid derivatives
None